Form 8-K · Current report
Align Technology 8-K, filed Jul 29, 2026
- Filed
- CIK
- 0001097149
- Accession no.
- 0001097149-26-000056
Summary
Align Technology announced plans to add three new independent directors, launch a strategic and operating model review, and increase its 2026 share repurchase commitment to $400 million–$500 million, following constructive discussions with Elliott Investment Management.
Key points
- Align Technology will add three new independent directors with experience in healthcare technology, medical devices, global operations, consumer technology, innovation, and scaling high-growth businesses.
- Align launched a strategic and operating model review supported by a global consulting firm to strengthen commercial execution, organizational effectiveness, resource optimization, and scalability.
- Align increased its 2026 share repurchase commitment to $400 million to $500 million of common stock.
- The actions followed constructive discussions with Elliott Investment Management, which said it is one of Align's largest investors.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 7.01Regulation FD Disclosure
- 9.01Financial Statements and Exhibits
From the filing
Item 7.01 Regulation FD Disclosure. On July 29, 2026, Align Technology, Inc. issued a press release titled “Align Technology Announces Strategic Initiatives Consistent with Long-term Growth and Shareholder Value Creation Objectives.” The full text of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. This information is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.